Thrivent Financial for Lutherans’s Amneal Pharmaceuticals AMRX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.41M	Buy	113,307 +58,698	+107%	+$788K	﹤0.01%	1680
2025 Q4	$688K	Sell	54,609 -38,075	-41%	-$436K	﹤0.01%	2130
2025 Q3	$927K	Buy	92,684 +35,076	+61%	+$315K	﹤0.01%	1817
2025 Q2	$466K	Hold	57,608	–	–	﹤0.01%	2172
2025 Q1	$483K	Buy	+57,608	New	+$481K	﹤0.01%	2088
2024 Q3	–	Sell	-94,839	Closed	-$602K	–	2510
2024 Q2	$602K	Sell	94,839 -4,050	-4%	-$25.7K	﹤0.01%	2142
2024 Q1	$599K	Hold	98,889	–	–	﹤0.01%	2160
2023 Q4	$600K	Buy	+98,889	New	+$440K	﹤0.01%	2141
2022 Q3	–	Sell	-51,282	Closed	-$164K	–	2403
2022 Q2	$164K	Buy	+51,282	New	+$186K	﹤0.01%	2373

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Thrivent Financial for Lutherans's AMRX Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Amneal Pharmaceuticals (AMRX) stake by 107% in Q1 2026, buying an estimated $788K and bringing the position to 113,307 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Thrivent Financial for Lutherans first reported a position in AMRX in Q2 2022 and has held it in 9 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Thrivent Financial for Lutherans held 113,307 shares of Amneal Pharmaceuticals worth $1.41M as of Q1 2026.
Thrivent Financial for Lutherans bought 58,698 Amneal Pharmaceuticals shares in Q1 2026, an estimated $788K.
Amneal Pharmaceuticals made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1680 holding.
Thrivent Financial for Lutherans first reported a position in Amneal Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.